Results 81 to 90 of about 5,258 (134)

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Seifert J, Grohmann R, Toto S, Reinhard MA, Bleich S, Erfurth A, Schüle C, Stübner S, Glocker C.   +8 more
europepmc   +1 more source

Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies. [PDF]

Neurol Res Pract
Hollander M, Mayer T, Klotz KA, Knake S, von Podewils F, Kurlemann G, Immisch I, Rosenow F, Schubert-Bast S, Strzelczyk A.   +9 more
europepmc   +1 more source

Patient-derived tissue slice cultures from endoscopic biopsies as a translational ex vivo model for inflammatory bowel diseases. [PDF]

Clin Exp Med
Werner J, Schiller L, Müller C, Lehmann J, Przybilla J, Schlosser T, Hoffmeister A, Kallendrusch S, Vissiennon C.   +8 more
europepmc   +1 more source

[Current dermatology guidelines in Germany: a selection of clinically relevant recommendations]. [PDF]

Dermatologie (Heidelb)
Pradeau MA, Kinberger M, Zouboulis CC, Chromy D, Jackowski J, Brockow K, Ruëff F, Nast A.   +7 more
europepmc   +1 more source

Aktuelle Bewertung von Pyrrolizidinalkaloiden in pflanzlichem Material

Julius-Kühn-Archiv, 2014
Steinhoff, Barbara
doaj   +1 more source

[Digital health applications from a regulatory perspective-Experiences and current developments]. [PDF]

Nervenarzt
Strauch F, Broich K.
europepmc   +1 more source

Mikrochemie

CHIMIA, 1952
Gertrud Bussmann
doaj   +1 more source

Patterns of Spontaneous Adverse Drug Reaction Reporting in Germany From 2012 to 2021. [PDF]

Pharmacol Res Perspect
Dubrall D, Domgörgen S, Christ P, Below M, Schmid M, Sachs B.   +5 more
europepmc   +1 more source

Therapeutic Strategies After Discontinuation of Valproate By Females with Epilepsy of Child-Bearing Potential: An Insurance Claims Database Study in France and the United Kingdom. [PDF]

Clin Drug Investig
Colas S, Longin J, Li X, Kaplan S, Bigat D, Bernard MA, Rouyer M, Czekalla J, Blin P, Bignon E, Schmitz B, Carcaillon-Bentata L.   +11 more
europepmc   +1 more source

[Androgen receptor-targeted therapies - avoid clinically relevant interactions]. [PDF]

Aktuelle Urol
Lipp HP, von Amsberg G, Merseburger AS, Rausch S, Schöning T, Klier J, Goebell PJ.   +6 more
europepmc   +1 more source